Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | FASN | P49327 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13021369 | 1.00 | CES2 (0.32) | CES2CES1FASNFFAR3HDAC3 | |
| SCHEMBL17940494 | 1.00 | CES2 (0.32) | CES2CES1FASNFFAR3HDAC3 | |
| SCHEMBL2833573 | 1.00 | CES2 (0.32) | CES2CES1FASNFFAR3HDAC3 | |
| SCHEMBL2833574 | 1.00 | CES2 (0.32) | CES2CES1FASNFFAR3HDAC3 | |
| SCHEMBL17940485 | 1.00 | CES2 (0.32) | CES2CES1FASNFFAR3HDAC3 | |
| SCHEMBL29927213 | 0.92 | CES2 (0.35) | CES2CES1FFAR3HDAC3HDAC1 | |
| SCHEMBL29455077 | 0.92 | CES2 (0.35) | CES2CES1FFAR3HDAC3HDAC1 | |
| SCHEMBL671371 | 0.92 | CES2 (0.35) | CES2CES1FFAR3HDAC3HDAC1 | |
| SCHEMBL4729241 | 0.83 | TDP1 (0.38) | TSHR | |
| SCHEMBL4729239 | 0.83 | TDP1 (0.38) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160213047-A1 | CARBONATE STIMULATION ENHANCER | T. HASEGAWA CO., LTD. (JP) | 2016-07-28 | — | — | US | disclosed |
| US-7795474-B2 | 6,8,10-undecatrien-3-one or 6,8,10-undecatrien-4-one, and aroma compositions | T. HASEGAWA CO., LTD. (JP) | 2010-09-14 | — | — | US | disclosed |
| US-7795474-B2 | 6,8,10-undecatrien-3-one or 6,8,10-undecatrien-4-one, and aroma compositions | T. HASEGAWA CO., LTD. (JP) | 2010-09-14 | — | — | US | disclosed |
| EP-2168940-A9 | 6,8,10-UNDECATRIEN-(3 OR 4)-ONE AND PERFUME COMPOSITION | T. Hasegawa Co., Ltd. (JP) | 2010-06-09 | — | — | EP | disclosed |
| US-20100137648-A1 | 6,8,10-UNDECATRIEN-3-ONE OR 6,8,10-UNDECATRIEN-4-ONE, AND AROMA COMPOSITIONS | T. HASEGAWA CO., LTD. (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20100137648-A1 | 6,8,10-UNDECATRIEN-3-ONE OR 6,8,10-UNDECATRIEN-4-ONE, AND AROMA COMPOSITIONS | T. HASEGAWA CO., LTD. (JP) | 2010-06-03 | — | — | US | disclosed |
| EP-2168940-A1 | 6,8,10-UNDECATRIEN-(3 OR 4)-ONE AND PERFUME COMPOSITION | T. Hasegawa Co., Ltd. (JP) | 2010-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137648-A1 | 6,8,10-UNDECATRIEN-3-ONE OR 6,8,10-UNDECATRIEN-4-ONE, AND AROMA COMPOSITIONS | OR10J3, ALOX5, TAS2R13 | CES2 2836/4885CES1 1759/4885FASN 41/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.